Literature DB >> 7906520

Evidence that the autonomic nervous system plays a major role in the L-NAME-induced hypertension in conscious rats.

R S Cunha1, A M Cabral, E C Vasquez.   

Abstract

The present study was designed to investigate the role of the autonomic nervous system in experimental hypertension induced by chronic administration of N-nitro-L-arginine methyl ester (L-NAME) in the drinking water (1 mg/mL) over 6 days. L-NAME ingestion caused a large rise in resting mean arterial pressure (MAP) (175 +/- 5 mm Hg) and heart rate (HR) (440 +/- 17 beats per minute) compared to nontreated control rats (resting MAP: 112 +/- 2 mm Hg and HR: 345 +/- 8 beats per minute). Ganglionic blockade induced by trimethaphan (5 mg/kg, intravenously) caused a significantly (P < .01) greater decrease in MAP (delta -86 +/- 7 mm Hg) compared to control rats MAP (delta -44 +/- 4 mm Hg). This strongly suggests that the level of central sympathetic tone in L-NAME-treated rats is much greater than in nontreated rats. Using atenolol and atropine alone and combined, the level of resting sympathetic drive to the heart was found to be significantly increased in L-NAME-treated rats compared to control rats. However, vagal tone to the heart was found to be virtually abolished in L-NAME-treated rats compared to control rats. These results indicate that an increase in central sympathetic drive plays an important role in the hypertension induced by chronic inhibition of nitric oxide synthesis with L-NAME.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7906520     DOI: 10.1093/ajh/6.9.806

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   2.689


  13 in total

Review 1.  Chronic nitric oxide inhibition model six years on.

Authors:  R Zatz; C Baylis
Journal:  Hypertension       Date:  1998-12       Impact factor: 10.190

2.  Early life stress enhances angiotensin II-mediated vasoconstriction by reduced endothelial nitric oxide buffering capacity.

Authors:  Analia S Loria; Kyu-Tae Kang; David M Pollock; Jennifer S Pollock
Journal:  Hypertension       Date:  2011-08-29       Impact factor: 10.190

Review 3.  Cardiovascular Autonomic Dysfunction in Chronic Kidney Disease: a Comprehensive Review.

Authors:  Ibrahim M Salman
Journal:  Curr Hypertens Rep       Date:  2015-08       Impact factor: 5.369

4.  Dysregulation of Cerebellar Adrenomedullin Signaling During Hypertension.

Authors:  Leticia Figueira; Anita Israel
Journal:  J Mol Neurosci       Date:  2017-06-26       Impact factor: 3.444

5.  Purinergic contraction of the rat vas deferens in L-NAME-induced hypertension: effect of sildenafil.

Authors:  Serap Gur; Suresh C Sikka; Gillian E Knight; Geoffrey Burnstock; Wayne J G Hellstrom
Journal:  Asian J Androl       Date:  2010-03-22       Impact factor: 3.285

6.  The role of nitric oxide synthesis in cardiovascular responses to acute hypoxia in the late gestation sheep fetus.

Authors:  L R Green; L Bennet; M A Hanson
Journal:  J Physiol       Date:  1996-11-15       Impact factor: 5.182

Review 7.  Current Approaches to Quantifying Tonic and Reflex Autonomic Outflows Controlling Cardiovascular Function in Humans and Experimental Animals.

Authors:  Ibrahim M Salman
Journal:  Curr Hypertens Rep       Date:  2015-11       Impact factor: 5.369

8.  Global disturbances in autonomic function yield cardiovascular instability and hypertension in the chromogranin a null mouse.

Authors:  Jiaur R Gayen; Yusu Gu; Daniel T O'Connor; Sushil K Mahata
Journal:  Endocrinology       Date:  2009-10-09       Impact factor: 4.736

9.  Sympathetic regulation of vascular function in health and disease.

Authors:  Rosa M Bruno; Lorenzo Ghiadoni; Gino Seravalle; Raffaella Dell'oro; Stefano Taddei; Guido Grassi
Journal:  Front Physiol       Date:  2012-07-24       Impact factor: 4.566

10.  Sildenafil ameliorates oxidative stress and DNA damage in the stenotic kidneys in mice with renovascular hypertension.

Authors:  Ananda T Dias; Bianca P Rodrigues; Marcella L Porto; Agata L Gava; Camille M Balarini; Flavia P S Freitas; Zaira Palomino; Dulce E Casarini; Bianca P Campagnaro; Thiago M C Pereira; Silvana S Meyrelles; Elisardo C Vasquez
Journal:  J Transl Med       Date:  2014-02-06       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.